|
| related topics |
| {product, liability, claim} |
| {property, intellectual, protect} |
| {stock, price, operating} |
| {product, candidate, development} |
| {stock, price, share} |
| {customer, product, revenue} |
| {product, market, service} |
| {operation, international, foreign} |
| {system, service, information} |
| {control, financial, internal} |
| {provision, law, control} |
| {acquisition, growth, future} |
|
|
Circumstances Associated with Our Acquisition Strategy and Internal Growth May Adversely Affect Our Operating Results
We May Not Be Able to Keep Pace with Technological Change or to Successfully Develop New Products with Wide Market Acceptance, Which Could Cause Us to Lose Business to Competitors
We Are Dependent Upon Our Arthroscopic System
Commercial Success of Products Outside of Our Core Businesses Is Uncertain
We Rely Exclusively on Our Costa Rica Facility to Manufacture Our High-Volume Coblation Products. If Our Costa Rica Facility is Unable to Produce Our Coblation Products in Sufficient Quantities or With Adequate Quality, or if Our Operations at Our Costa Rican Facility are Disrupted, We Will Be Forced to Find Alternative Manufacturing Options, Which Could Cause Sales to be Delayed or Increase Our Manufacturing Costs, Which Could Harm Our Reputation and Profitability
Our Business May Become Increasingly Susceptible to Risks Associated with International Operations
Our Operating Results May Fluctuate
The Market Price of Our Stock May Be Highly Volatile
We May Be Unable to Effectively Protect Our Intellectual Property
We May Become Subject to Patent Litigation
We Must Obtain Governmental Clearances or Approvals Before We Can Sell Our Products; We Must Continue to Comply with Applicable Laws and Regulations
We Face Uncertainty Over Reimbursement
We Are Dependent on Key Suppliers
We Have Limited Marketing and Sales Experience
Delaware Law, Provisions in Our Charter and Our Stockholder Rights Plan Could Make the Acquisition of Our Company By Another Company More Difficult
Beginning with Fiscal 2006, We are Required to Recognize Expense for Stock-Based Compensation Related to Employee Stock Options and Employee Stock Purchases, and the Recognition of This Expense Could Cause the Trading Price of Our Common Stock to Decline
Full 10-K form ▸
|
|
| related documents |
| 880432--9/26/2008--MISONIX_INC |
| 911649--4/2/2007--STRATEGIC_DIAGNOSTICS_INC/DE/ |
| 768408--6/24/2010--CYANOTECH_CORP |
| 880432--9/28/2009--MISONIX_INC |
| 1042173--3/5/2009--SCIENTIFIC_LEARNING_CORP |
| 911649--3/31/2006--STRATEGIC_DIAGNOSTICS_INC/DE/ |
| 880432--9/28/2007--MISONIX_INC |
| 862668--10/12/2010--ESCALON_MEDICAL_CORP |
| 27096--9/13/2006--DATASCOPE_CORP |
| 27096--9/12/2007--DATASCOPE_CORP |
| 912093--8/31/2010--JDS_UNIPHASE_CORP_/CA/ |
| 714256--4/4/2008--MB_SOFTWARE_CORP |
| 1006045--4/10/2008--IRIDEX_CORP |
| 1000180--2/28/2007--SANDISK_CORP |
| 727634--3/30/2006--COMMUNICATION_INTELLIGENCE_CORP |
| 1102934--11/27/2007--CABOT_MICROELECTRONICS_CORP |
| 862668--9/29/2008--ESCALON_MEDICAL_CORP |
| 768408--6/25/2009--CYANOTECH_CORP |
| 727634--3/26/2007--COMMUNICATION_INTELLIGENCE_CORP |
| 946356--3/9/2007--OAKLEY_INC |
| 768408--8/16/2007--CYANOTECH_CORP |
| 810084--4/2/2007--BIOJECT_MEDICAL_TECHNOLOGIES_INC |
| 768408--6/28/2006--CYANOTECH_CORP |
| 780127--1/12/2006--SYNOVIS_LIFE_TECHNOLOGIES__INC |
| 1040130--6/1/2009--PETMED_EXPRESS_INC |
| 1040130--6/1/2010--PETMED_EXPRESS_INC |
| 9892--2/27/2007--BARD_C_R_INC_/NJ/ |
| 9892--2/26/2008--BARD_C_R_INC_/NJ/ |
| 1042173--3/11/2008--SCIENTIFIC_LEARNING_CORP |
| 833140--3/20/2006--ENPATH_MEDICAL_INC |
|